<seo title="Baxter International" metakeywords="introduction baxter international,baxter global healthcare,pharmaceuticals baxter,management baxter international" metadescription="Baxter International was founded in 1931 by Donald Baxter, a pharmacist in Chicago, Illinois." />
===Introduction to Baxter International===

Baxter International Inc. is a global healthcare company that develops, manufactures, and markets products and services that save and sustain the lives of people with chronic and acute medical conditions. Founded in 1931, Baxter has grown to become a leader in the healthcare industry, with operations in more than 100 countries and products sold in more than 200 countries. Baxter’s products and services span a wide range of medical disciplines, including renal, nutrition, biosurgery, and specialty pharmaceuticals. The company’s mission is to advance the practice of medicine and improve patient outcomes.
===History of Baxter International===

Baxter International was founded in 1931 by Donald Baxter, a pharmacist in Chicago, Illinois. The company began as a small drugstore, but quickly grew to become a leader in the healthcare industry. In the 1950s, Baxter began to expand its product offerings to include medical devices and pharmaceuticals. In the 1960s, the company began to focus on the development of products for the treatment of chronic and acute medical conditions. In the 1970s, Baxter began to expand its operations internationally, and in the 1980s, the company began to focus on the development of biotechnology products. Today, Baxter is a global healthcare company with operations in more than 100 countries and products sold in more than 200 countries.
===Financial Performance of Baxter International===

Baxter International has a strong [[Financial Performance|financial performance]]. In 2020, the company reported total revenues of $11.3 billion, an increase of 4.3% from the previous year. The company’s [[Net Income|net income]] was $1.2 billion, an increase of 8.3% from the previous year. Baxter’s [[Operating Margin|operating margin]] was 17.2%, an increase of 0.7% from the previous year. The company’s [[Return On Equity|return on equity]] was 17.3%, an increase of 0.7% from the previous year.
===Products and Services of Baxter International===

Baxter International offers a wide range of products and services for the treatment of chronic and acute medical conditions. The company’s products and services span a wide range of medical disciplines, including renal, nutrition, biosurgery, and specialty pharmaceuticals. Baxter’s products include dialysis machines, infusion pumps, nutrition products, biosurgery products, and specialty pharmaceuticals. The company also offers services such as patient support programs, clinical education, and reimbursement support.
===Management of Baxter International===

Baxter International is led by its Chairman and CEO, José (Joe) E. Almeida. Almeida has been with the company since 2003 and has held various leadership positions, including President and Chief Operating Officer. He was appointed Chairman and CEO in 2016. Almeida is supported by a team of experienced executives, including Chief Financial Officer, Chief Operating Officer, Chief [[Human Resources|Human Resources]] Officer, and [[Chief Technology Officer|Chief Technology Officer]].
===Conclusion===

Baxter International is a 